Spots Global Cancer Trial Database for anemia, aplastic

Every month we try and update this database with for anemia, aplastic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Identifying Characteristics of Bone Marrow Failure Syndromes	NCT00315419	Bone Marrow Fai... Anemia, Aplasti... Myelodysplastic... Hemoglobinuria,... Red-Cell Aplasi... Purpura, Thromb... Leukemia, Lymph...		11 Years -	Office of Rare Diseases (ORD)
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study	NCT03733249	Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ...	Rimiducid rivogenlecleuce...	1 Month - 18 Years	Bellicum Pharmaceuticals
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant	NCT02065869	Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Osteopetrosis Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ...	BPX-501 T cells Rimiducid	1 Month - 18 Years	Bellicum Pharmaceuticals
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States	NCT00997386	Hematologic Neo... Multiple Myelom... Anemia, Aplasti... Hemoglobinuria,... Myelofibrosis	busulfan, and m...	18 Years - 75 Years	University of Arizona
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant	NCT02065869	Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Osteopetrosis Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ...	BPX-501 T cells Rimiducid	1 Month - 18 Years	Bellicum Pharmaceuticals
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States	NCT00997386	Hematologic Neo... Multiple Myelom... Anemia, Aplasti... Hemoglobinuria,... Myelofibrosis	busulfan, and m...	18 Years - 75 Years	University of Arizona
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study	NCT03733249	Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ...	Rimiducid rivogenlecleuce...	1 Month - 18 Years	Bellicum Pharmaceuticals
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer	NCT00975975	Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Non-Hodgkin's L... Hodgkin's Disea... Multiple Myelom... Myelofibrosis Anemia, Aplasti... Hemoglobinuria,...	Basiliximab	18 Years -	Indiana University
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells	NCT00692926	MDS Anemia, Aplasti... Inborn Errors o... Congenital Marr... Congenital Immu...	ALDHbr Umbilica...	- 55 Years	Duke University
Cord Blood Stem Cell Transplantation Study (COBLT)	NCT00000603	Anemia, Aplasti... Fanconi Anemia Hematologic Dis... Leukemia Neoplasms Severe Combined... Hematopoietic S... Myelodysplastic...	stem cell trans...	- 55 Years	National Heart, Lung, and Blood Institute (NHLBI)
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer	NCT00975975	Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Non-Hodgkin's L... Hodgkin's Disea... Multiple Myelom... Myelofibrosis Anemia, Aplasti... Hemoglobinuria,...	Basiliximab	18 Years -	Indiana University
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant	NCT02065869	Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Osteopetrosis Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ...	BPX-501 T cells Rimiducid	1 Month - 18 Years	Bellicum Pharmaceuticals
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor	NCT00393380	Leukemia, Myelo... Anemia, Aplasti... Myelofibrosis Lymphoma Hodgkin Disease Leukemia, Lymph... Leukemia, Myelo... Leukemia, Lymph...	Parathyroid Hor...	18 Years - 45 Years	The Emmes Company, LLC
Cord Blood Stem Cell Transplantation Study (COBLT)	NCT00000603	Anemia, Aplasti... Fanconi Anemia Hematologic Dis... Leukemia Neoplasms Severe Combined... Hematopoietic S... Myelodysplastic...	stem cell trans...	- 55 Years	National Heart, Lung, and Blood Institute (NHLBI)
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors	NCT00618969	Hematologic Neo... Anemia, Aplasti... Hemoglobinuria,... Multiple Myelom...	haploidentical ...	18 Years - 75 Years	University of Arizona
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies	NCT00683046	Acute Myelogeno... Lymphoid Leukem... Chronic Myeloge... Malignant Lymph... Hodgkin's Disea... Chronic Lymphoc... Myeloproliferat... Anemia, Aplasti... Myelodysplastic...	Fludarabine Melphalan Stem cells Campath	- 100 Years	University of Chicago
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies	NCT00683046	Acute Myelogeno... Lymphoid Leukem... Chronic Myeloge... Malignant Lymph... Hodgkin's Disea... Chronic Lymphoc... Myeloproliferat... Anemia, Aplasti... Myelodysplastic...	Fludarabine Melphalan Stem cells Campath	- 100 Years	University of Chicago

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: